New Classifications of Five Distinct “Sleep” Profi... ...
A Professional Overview of Hypertension ...
High-speed imaging tracks live brain cell activity...
Drug candidate slows motor neuron disease progress...
Drug candidate slows motor neuron disease progress...
Mark Cuban: A Master Disrupter for American Health...
Superbugs on your plate: How antimicrobial resistance spread...
June 13,2026
Can marijuana cause lung cancer?...
June 12,2026
Standard depression screening could be missing key symptoms ...
June 11,2026
More women are having babies later in life. How to improve y...
June 10,2026
For severe babesiosis, red blood cell exchange is associated...
June 09,2026
Cause or effect? Study answers question about gene linked wi...
June 08,2026
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
Eye Infections (Updated) | Clinical Medicine...
Announcement of the 2025 Nobel Prize in ...
Dr. Fauci among hundreds who've contract...
Why are young, healthy adults experienci...
Reprogramming Stem Cells Could Cure Type...
More News
Why Psoriasis Causes Hair Loss

Why Psoriasis Causes Hair Loss

Hair care may involve using medicated shampoo on a strict washing scheduleByAshley Olivine, Ph.D., MPHPublished on February 07, 2023Medically reviewed bySusan Bard, MDScalp pso
Immunology & Rheumatology December 20,2023
Why Psoriasis Causes Hair Loss

Why Psoriasis Causes Hair Loss

Hair care may involve using medicated shampoo on a strict washing scheduleByAshley Olivine, Ph.D., MPHPublished on February 07, 2023Medically reviewed bySusan Bard, MDScalp pso
Immunology & Rheumatology December 20,2023
How to Prevent or Slow Down Continued Hair Loss

How to Prevent or Slow Down Continued Hair Loss

ByMark GurarieUpdated on December 18, 2023Medically reviewed bySusan Bard, MDWhether caused by genetics, chemotherapy, weight loss surgery, stress, or something else, hair loss
Dermatology December 20,2023
How to Prevent or Slow Down Continued Hair Loss

How to Prevent or Slow Down Continued Hair Loss

ByMark GurarieUpdated on December 18, 2023Medically reviewed bySusan Bard, MDWhether caused by genetics, chemotherapy, weight loss surgery, stress, or something else, hair loss
Dermatology December 20,2023
Low blood phosphate levels may be linked to neurological side effects from CAR T-cell therapy

Low blood phosphate levels may be linked to neurological side effects from CAR T-cell therapy

byAmerican Association for Cancer ResearchCredit: Pixabay/CC0 Public DomainIncidence and severity of neurological side effects from chimeric antigen receptor (CAR) T-cell therapy were higher in
World medicine December 20,2023
Low blood phosphate levels may be linked to neurological side effects from CAR T-cell therapy

Low blood phosphate levels may be linked to neurological side effects from CAR T-cell therapy

byAmerican Association for Cancer ResearchCredit: Pixabay/CC0 Public DomainIncidence and severity of neurological side effects from chimeric antigen receptor (CAR) T-cell therapy were higher in
World medicine December 20,2023
Lower education and mild cognitive impairment may hinder successful completion of home colorectal screening tests

Lower education and mild cognitive impairment may hinder successful completion of home colorectal screening tests

byAmerican Academy of Family PhysiciansExamples of abnormal clock drawings. Credit:The Annals of Family Medicine(2022). DOI: 10.1370/afm.2855While many patients find at-home colorect
World medicine December 20,2023
Lower education and mild cognitive impairment may hinder successful completion of home colorectal screening tests

Lower education and mild cognitive impairment may hinder successful completion of home colorectal screening tests

byAmerican Academy of Family PhysiciansExamples of abnormal clock drawings. Credit:The Annals of Family Medicine(2022). DOI: 10.1370/afm.2855While many patients find at-home colorect
World medicine December 20,2023
Low income linked to high recurrence risk, poorer survival in women with ER-positive breast cancer

Low income linked to high recurrence risk, poorer survival in women with ER-positive breast cancer

by Roswell Park Comprehensive Cancer CenterCredit: Unsplash/CC0 Public DomainPatients with early-stage estrogen receptor-positive breast cancer who live in low-income neighborhoods are likelier to hav
Oncology December 20,2023
Low income linked to high recurrence risk, poorer survival in women with ER-positive breast cancer

Low income linked to high recurrence risk, poorer survival in women with ER-positive breast cancer

by Roswell Park Comprehensive Cancer CenterCredit: Unsplash/CC0 Public DomainPatients with early-stage estrogen receptor-positive breast cancer who live in low-income neighborhoods are likelier to hav
Oncology December 20,2023
Patients in lower-income countries receive less timely cancer diagnoses

Patients in lower-income countries receive less timely cancer diagnoses

byPublic Library of ScienceCredit: Unsplash/CC0 Public DomainThe time it takes a cancer patient to see a doctor, receive a diagnosis and begin treatment can vary greatly depending on the patient
Oncology December 20,2023
Patients in lower-income countries receive less timely cancer diagnoses

Patients in lower-income countries receive less timely cancer diagnoses

byPublic Library of ScienceCredit: Unsplash/CC0 Public DomainThe time it takes a cancer patient to see a doctor, receive a diagnosis and begin treatment can vary greatly depending on the patient
Oncology December 20,2023
A top-down study of isogenic human non-metastatic and metastatic colorectal cancer cell lines

A top-down study of isogenic human non-metastatic and metastatic colorectal cancer cell lines

by Bob Yirka , Medical XpressSchematic of the experimental design. (A) Schematic design of the TDP study of metastatic (SW620) and nonmetastatic (SW480) CRC cells using CZE-ESI-MS/MS and LC-CZE-ESI-MS
Oncology December 20,2023
A top-down study of isogenic human non-metastatic and metastatic colorectal cancer cell lines

A top-down study of isogenic human non-metastatic and metastatic colorectal cancer cell lines

by Bob Yirka , Medical XpressSchematic of the experimental design. (A) Schematic design of the TDP study of metastatic (SW620) and nonmetastatic (SW480) CRC cells using CZE-ESI-MS/MS and LC-CZE-ESI-MS
Oncology December 20,2023
More News
Week’s Top
Podcasts
... Preparing for a tough exam? A tough gym workout could help with your studies ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... Brain activity goes to extremes in soccer fans, neuroimaging reveals ...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com